Anti-VEGF injection was administered at 323/820 (39.4%) visits where presence of fovea involving oedema could not be confirmed by the RCs (DME 177/428 [41.4%] visits; RVO 146/392 [37.2%] visits). Here, VEGFA is linked to edema.